Overview

The Effect of Lacosamide in Peripheral Neuropathic Pain

Status:
Recruiting
Trial end date:
2022-10-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to compare the change in pain intensity during treatment with a sodium-channel blocker (lacosamide) in patients with peripheral neuropathic pain with and without the irritable nociceptor phenotype.
Phase:
Phase 2
Details
Lead Sponsor:
Danish Pain Research Center
Collaborator:
Odense University Hospital
Treatments:
Lacosamide